All Pathways
PsychiatryEmergency

Acute Agitation Management (AAEP Project BETA)

Acute Agitation Management (AAEP Project BETA): Acute Agitation Identified → ⚠️ Staff Safety First → Verbal De-escalation (FIRST LINE) → De-escalation S...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Acute Agitation Identified

    Patient presenting with agitation, aggression, or behavioral emergency

    1. Warning

      ⚠️ Staff Safety First

      Ensure adequate staff, clear exit routes, remove dangerous objects

      • Never approach alone
      • Maintain safe distance
      • Remove ties, lanyards, stethoscopes
      • Have security present
      1. Action

        Verbal De-escalation (FIRST LINE)

        Always attempt verbal de-escalation before medications

        • Speak calmly and slowly
        • Identify yourself and role
        • Offer choices when possible
        • Acknowledge patient's feelings
        • Avoid threatening body language
        • Maintain comfortable distance
        1. Decision

          De-escalation Successful?

          Assess if patient is responding to verbal intervention

          1. Outcome

            Agitation Controlled

            Continue monitoring, address underlying cause

          2. Decision

            Identify Likely Etiology

            Determine most likely cause of agitation

            • Psychiatric: psychosis, mania, personality disorder
            • Intoxication: alcohol, stimulants, PCP, anticholinergics
            • Withdrawal: alcohol, benzodiazepines, opioids
            • Medical: delirium, hypoglycemia, hypoxia, infection
            1. Action

              Primary Psychiatric (Psychosis/Mania)

              Antipsychotic-based regimen preferred

              • First line: Olanzapine 10mg IM OR Ziprasidone 20mg IM
              • Alternative: Haloperidol 5-10mg IM + Lorazepam 2mg IM
              • Droperidol 5-10mg IM if available (fastest onset)
              • Avoid benzodiazepine monotherapy
              • May repeat in 20-30 min if needed
              1. Decision

                Response to Initial Medication?

                Reassess 15-30 minutes after administration

                1. Action

                  Post-Medication Monitoring

                  Essential safety monitoring after sedation

                  • Continuous pulse oximetry
                  • Q15min vitals initially
                  • Airway positioning (lateral if needed)
                  • ECG if high-dose antipsychotics (QTc)
                  • Have reversal agents available
                  1. Outcome

                    Patient Stabilized

                    Transition to ongoing psychiatric/medical care

                2. Action

                  Escalate Treatment

                  If inadequate response after initial dose

                  • Repeat same medication at same/higher dose
                  • Add complementary agent (antipsychotic + benzodiazepine)
                  • Consider ketamine 4-5mg/kg IM for severe agitation
                  • Maximum haloperidol: 20mg/24hr recommended
                  • Monitor for respiratory depression with combinations
                  1. Warning

                    Consider ICU/Higher Level of Care

                    For refractory agitation or medical compromise

                    • Propofol/dexmedetomidine infusion
                    • Intubation if airway compromise
                    • Continuous sedation monitoring
            2. Action

              Intoxication/Unknown Etiology

              Consider ketamine or combination therapy

              • Alcohol/unknown: Haloperidol 5mg + Lorazepam 2mg IM (B52)
              • Stimulants: Benzodiazepines preferred (Lorazepam 2-4mg IM)
              • Severe: Ketamine 4-5mg/kg IM (rapid onset)
              • PCP: Benzodiazepines, avoid antipsychotics if possible
              • Anticholinergic: Physostigmine if identified
            3. Action

              Withdrawal States

              Benzodiazepines are first-line

              • Alcohol/benzo withdrawal: Lorazepam 2-4mg IM/IV
              • May need high doses for severe withdrawal
              • Avoid antipsychotics (lower seizure threshold)
              • Monitor for seizures
              • Consider phenobarbital for refractory cases
            4. Warning

              Medical Delirium

              Treat underlying cause, use minimal sedation

              • Identify and treat underlying cause FIRST
              • Hypoglycemia: Dextrose
              • Hypoxia: Oxygen, airway management
              • Infection: Antibiotics, source control
              • If sedation needed: Low-dose haloperidol 0.5-2mg
              • Avoid benzodiazepines (may worsen delirium)

Guideline Source

The Psychopharmacology of Agitation: Consensus Statement of the AAEP Project BETA Psychopharmacology Workgroup

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Verbal de-escalation should ALWAYS be attempted first
  • Does not replace clinical judgment in specific contexts
  • Drug dosing may need adjustment for elderly or medically compromised
  • Specific antidotes/reversal agents not detailed
  • Pediatric dosing not included - requires specialist input

Contraindicated Populations

pediatric

Applicable Regions

USEUGlobal

EU: Haloperidol IV restricted in some countries due to QT risk

US: Droperidol availability varies by institution

Version 1Next review: 2028-01-01

Frequently Asked Questions

What is the Acute Agitation Management (AAEP Project BETA)?

The Acute Agitation Management (AAEP Project BETA) is a emergency clinical algorithm for Psychiatry. It provides a structured decision tree to guide clinical decision-making, based on The Psychopharmacology of Agitation: Consensus Statement of the AAEP Project BETA Psychopharmacology Workgroup.

What guideline is the Acute Agitation Management (AAEP Project BETA) based on?

This algorithm is based on The Psychopharmacology of Agitation: Consensus Statement of the AAEP Project BETA Psychopharmacology Workgroup (DOI: 10.5811/westjem.2011.9.6867).

What are the limitations of the Acute Agitation Management (AAEP Project BETA)?

Known limitations include: Verbal de-escalation should ALWAYS be attempted first; Does not replace clinical judgment in specific contexts; Drug dosing may need adjustment for elderly or medically compromised; Specific antidotes/reversal agents not detailed; Pediatric dosing not included - requires specialist input. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Acute Agitation Management (AAEP Project BETA) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free